Clinical trial for estrogen on endometrial receptivity and embryo implantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028036

Enrollment

Unknown

Registered

2019-12-08

Start date

2020-10-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial receptivity

Interventions

Experimental group:stop estrogen during luteal phase

control group:routine e+p treatment

Eligibility

Sex/Gender

Female

Age

21 Years to 35 Years

Inclusion criteria

Inclusion criteria: Aged between 21 to 35years; infertile factor: Pure fallopian tube factor or male factor; in case of embryo transfer, at least one embryo evaluation >=8C/II0.

Exclusion criteria

Exclusion criteria: Uterine abnormalities: intrauterine adhesions, endometrial polyps; uterine fibroids; adenomyosis; poor healing of uterine incisions.

Design outcomes

Primary

Measure	Time frame
thickness/pattern of endometrium;embryo implantation rate;bio-markers of endometrial receptivity;	—

Countries

China

Contacts

Public ContactZhao Jing

Xiangya Hospital, Central South University

zjclivia@csu.edu.cn+86 15874131927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026